Travere Therapeutics TVTX
NASDAQ TVTX
$56.93 +0.08 (+0.14%)
At close: Oct 2, 2026 · 4:00 PM EDT

Travere Therapeutics (TVTX) Cost of Revenue (2014 - 2026)

Updated

Travere Therapeutics (TVTX) posted Cost of Revenue of $2.17 million for Q2 2026, up 42.9% from $1.52 million a year earlier and up 11.5% from the prior quarter.

Analysis

Travere Therapeutics (TVTX) Cost of Revenue (2014 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Cost of Revenue at Travere Therapeutics was $8.26 million, down 20.4% year-over-year; for FY2025, it came in at $10.34 million, up 33.5% from FY2024.

  • Annual Cost of Revenue shows a five-year compound annual growth rate of 11.0% (FY2020 to FY2025).
  • In prior years, Travere Therapeutics' Cost of Revenue was $7.74 million in FY2024 (-32.4%), $11.45 million in FY2023 (+159.0%), $4.42 million in FY2022 (+15.8%) and $3.82 million in FY2021 (-37.7%).
  • Quarterly Cost of Revenue has run from a low of -$1.07 million in Q4 2021 to a high of $4.68 million in Q1 2025 over five years.
  • On a year-over-year basis, Cost of Revenue increased in three of the last eight quarters, with growth averaging 18.6%.
  • The strongest year-over-year quarter for Cost of Revenue in the past five years was Q4 2023, with growth of 425.8%; the weakest was Q1 2024, with a decline of 63.7%.
  • According to Business Quant data, Cost of Revenue for the three prior quarters was $1.95 million (Q1 2026), $2.55 million (Q4 2025) and $1.59 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 8.05 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.29 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.52 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.58 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.09 Bn
10 Travere Therapeutics 5.36 Bn 4.96 Bn 167.41 Mn 2.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.17 Mn
Mar 31, 2026 1.95 Mn
Dec 31, 2025 2.55 Mn
Sep 30, 2025 1.59 Mn
Jun 30, 2025 1.52 Mn
Mar 31, 2025 4.68 Mn
Dec 31, 2024 2.55 Mn
Sep 30, 2024 1.63 Mn
Jun 30, 2024 2.06 Mn
Mar 31, 2024 1.50 Mn
Dec 31, 2023 4.56 Mn
Sep 30, 2023 1.29 Mn
Jun 30, 2023 1.45 Mn
Mar 31, 2023 4.15 Mn
Dec 31, 2022 868,000.00
Sep 30, 2022 1.11 Mn
Jun 30, 2022 2.05 Mn
Mar 31, 2022 2.14 Mn
Dec 31, 2021 -1.07 Mn
Sep 30, 2021 1.59 Mn
API Access

Travere Therapeutics Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=TVTX&period=max&api_key=YOUR_API_KEY